9 min listen
Episode 6: Gene editing
FromA view on
ratings:
Length:
10 minutes
Released:
Oct 15, 2020
Format:
Podcast episode
Description
Since the arrival of Crispr in 2009, gene editing has made its way into labs. Its groundbreaking importance was acknowledged through the 2020 Nobel Prize in Chemistry. Expanding gene editing for medical treatments, Cellectis focuses its 20 years of experience on developing cancer immunotherapies.
Curious to Know More?
Cellectis CEO André Choulika explains the technology of allogenic gene editing they invented in this episode of the podcast "A View On."
Curious to Know More?
Cellectis CEO André Choulika explains the technology of allogenic gene editing they invented in this episode of the podcast "A View On."
Released:
Oct 15, 2020
Format:
Podcast episode
Titles in the series (32)
Episode 2: Cell-penetrating peptides for cancer treatment: One of the limitations of cancer therapy is off-target activity, which often has devastating effects on patients’ life quality. A novel strategy pursued by Cybrexa Therapeutics uses treatments specifically targeting solid tumors by taking advantage of on... by A view on